Should I buy Venture Corp stock in 2025?

Why trust HelloSafe?

At HelloSafe, our expert has been monitoring the performance of Venture Corp for over three years. Each month, tens of thousands of users in Singapore rely on us to help them understand market trends and pinpoint the top investment opportunities. Our analyses are provided strictly for informational purposes and should not be considered as investment advice. In line with our ethical charter, we have never been, and will never be, compensated by Venture Corp.

What is Venture Corp?

How much is Venture Corp stock?

The price of Venture Corp stock is falling this week. As of now, the stock trades at SGD 11.07, reflecting a 0.27% decline over the past 24 hours and a 0.91% drop for the week. Venture Corp’s market capitalisation stands at SGD 3.19 billion, with an average daily trading volume of 773,130 shares over the past three months. It currently shows a price-to-earnings (P/E) ratio of 13.12, offers a robust dividend yield of 6.78%, and has a beta of 0.54, suggesting relatively low share price volatility. Investors may find the stable yield attractive, though recent market trends indicate cautious sentiment in the near term.

Our full analysis on Venture Corp stock

We have conducted a thorough review of Venture Corporation Limited’s most recent financial results, integrated with an in-depth analysis of the stock’s three-year performance trajectory. Employing our proprietary blend of quantitative models and qualitative research, we synthesised diverse datasets—spanning financial metrics, technical signals, comparative peer benchmarks, and real-time market developments. So, what are the key factors that could position Venture Corp as a compelling strategic entry into the technology manufacturing sector as we enter 2025?

Recent Performance and Market Context

Venture Corp (SGX: V03) demonstrates a classic case of near-term market scepticism juxtaposed with long-term potential. As of 9 May 2025, the stock traded at SGD 11.07, reflecting a decrease of 20.93% over the past 12 months and a 15.14% drop from its 6-month high of SGD 15.64. This pullback is set against a backdrop of generally lacklustre sentiment in the broader EMS sector, as global supply chain adjustments and cyclical softness in electronics demand weighed on results.

However, this challenging price action reveals features that now tilt the fundamental risk/reward balance in favour of prospective buyers. Notably:

• The average daily volume remains robust at 773,130 shares, indicating continued institutional and retail confidence.
• Latest dividend declaration of SGD 0.50 per share (ex-dividend date: 5 May 2025) underscores management’s conviction in cash flow resilience—remarkable, as earnings faced cyclical pressure.
• Straits Times Index inclusion anchors Venture’s profile for index funds and institutional flows, maintaining consistent market liquidity.

At the macro level, the Singapore manufacturing sector is showing signs of bottoming, with the electronics PMI having staged a steady recovery in early 2025. Meanwhile, a global pivot towards AI, smart manufacturing, and next-generation communications continues to enhance the addressable market for EMS players. Against this sectoral reset, Venture Corp’s global diversification, healthy balance sheet, and strong customer base form a solid floor for a return to growth.

Technical Analysis

While technical signals are currently neutral to negative, these very indicators spotlight an emerging opportunity. The current price of SGD 11.07 is below all major moving averages—20-day (SGD 11.06), 50-day (SGD 11.09), 100-day (SGD 11.28), and 200-day (SGD 11.09)—reflecting a consolidative phase.

• RSI (14) at 42.72 is in the lower neutral band—neither overbought nor oversold—suggesting that much of the recent selling pressure may already be in the price.
• MACD (-0.016) confirms subdued momentum but is not in deeply negative territory, creating the ideal backdrop for reversal hunters.
• Support Levels at SGD 11.00 and SGD 10.17 (the 52-week low) act as strong psychological and technical floors, while key resistance at SGD 11.13, 11.50, and 12.00 sets clear targets for bullish reversals.

Importantly, price action below major averages often acts as a precursor to mean-reversion rallies, especially for fundamentally solid companies with healthy cash flows. Momentum traders may soon find a favourable risk/reward at these levels, making the stock’s consolidation phase a case for renewed attention.

Fundamental Analysis

Revenue, Profitability, and Strategic Expansion

Venture Corp’s fundamental profile remains robust. With trailing twelve-month revenue of SGD 2.74 billion and net income of SGD 245.03 million, the company generates ample free cash flow (operating cash flow: SGD 482.5 million) and maintains an attractive profitability profile even amidst headwinds.

• Net cash of SGD 1.32 billion (more than 35% of market cap) is a strong competitive advantage, providing ample flexibility for strategic investments, product development, or opportunistic M&A.
• Revenue decline of 8.20% YoY and 9.00% contraction in earnings are certainly points for monitoring, but these are in line with cyclical patterns observed across the EMS sector globally. Notably, few peers can claim Venture’s combination of scale, balance sheet strength, and entrenched client relationships.

Dividend and Valuation

• Dividend yield stands at a compelling 6.78%, outclassing the sector and major Singapore blue chips. This is further supported by an 88.86% payout ratio—high but manageable given the company’s cash hoard.
• P/E ratio of 13.12 (forward P/E: 15.95) positions Venture Corp attractively both versus its own historical averages and global EMS comparables, indicating much of the cyclical slowdown is already discounted in the price.
• PEG and P/S multiples, while trailing higher-growth US peers, remain clear value indicators within the context of Singapore’s quality-focused investor base.

Structural Strengths

• Diversified revenue streams: Engagements across Life Sciences, MedTech, Smart Industrial, and Next-Gen Communications reduce earnings volatility and enhance resilience to sector rotation.
• Global reach: Manufacturing and R&D sites spanning Singapore, Malaysia, China, Europe, and the US insulate the company from regional shocks and enable it to serve global tech leaders.
• Reputation: Decades-long partnerships with Fortune 500 clients and prominent tech firms reinforce switching costs and customer stickiness, underpinning long-term value.

Volume and Liquidity

Venture Corp's liquidity metrics point to genuine market conviction. Sustained high average trading volume (773,130 shares daily) demonstrates that even during correction phases, buyer interest remains pronounced.

• Public float of 264.05 million shares allows for efficient price discovery and positions the stock favourably for institutional inflows, index fund allocations, and high-frequency trading activity.
• Tight bid-ask spreads on the SGX further underscore Venture’s attractiveness as a liquid, large-cap equity—critical for both retail and professional investors seeking dynamic entry and exit points.

Catalysts and Positive Outlook

With cyclical pressures now appearing priced in, several catalysts offer reasons to look beyond the recent softness:

• Strong cash reserves (SGD 1.32 billion) arm management with options to fund organic innovation, strategic jumps (such as bolt-on M&A) or enhanced capital returns should market conditions stabilise.
• Business diversification into Life Sciences & MedTech continues to pay off, as secular growth in healthcare technology is projected to outpace traditional electronics markets over the next decade.
• Resilient dividend policy signals boardroom confidence and strengthens the stock’s appeal among Singaporean and regional income-seeking investors.
• ESG and sustainability initiatives—with recent investments in eco-friendly manufacturing and digitalisation—show an awareness of investor priorities and pending regulatory shifts that can unlock new capital sources (including global ESG funds).

Broader tech tailwinds, such as the intensifying adoption of AI, IoT, and advanced industrial automation, reinforce the addressable market and strengthen the multi-year narrative. Venture Corp’s global footprint and established customer relationships should allow it to capture rising demand, as technology product cycles accelerate through 2025.

Investment Strategies

Venture Corp’s current setup appears to support a range of buy-side strategies:

• Short-Term Opportunity: The stock currently sits at key multi-year support levels (SGD 11.00–10.17), offering an attractive technical entry for traders seeking mean-reversion rallies or dividend capture strategies—particularly ahead of the May 19, 2025 dividend payment.
• Medium-Term Recovery Play: Technical consolidation, stabilising sector PMIs, and cyclical inflection potential (as electronics restocking gathers pace globally) indicate room for upside. Portfolio managers may find a favourable entry ahead of anticipated sectoral improvements by late 2025.
• Long-Term Compounder: For investors seeking exposure to a best-in-class, cash-rich EMS franchise with a proven record of dividend growth and innovation-led expansion, Venture Corp seems well positioned to benefit from shifts towards MedTech, smart manufacturing, and resilient supply chains globally.

The presence of a strong support base, rare valuation discount, and multiple upcoming catalysts—be it business investments, sector recovery, or technical mean reversion—combine to create a particularly timely window for strategic positioning.

Is it the Right Time to Buy Venture Corp?

In summary, Venture Corporation stands out for its blend of financial stability, value, and yield at a time when the EMS sector may be primed for a renewed upcycle. Key points for prospective investors include:

• High and well-covered dividend yield—unmatched among regional peers and backed by a fortress-like balance sheet.
• Global client reach and diversification that reduce business risk.
• Compelling valuation—with a P/E below historical averages despite a sector-leading cash position.
• Technical setup at or near long-term support levels signals a potential bullish reversal, especially in the context of sector-wide recovery.
• Liquidity and STI inclusion make Venture Corp a core Singapore blue chip, sought after by institutional and retail investors alike.
• Clear, multi-year growth catalysts in MedTech, industrial automation, and global technology cycles.

From any rational, fundamentals-based review, Venture Corp seems to represent an excellent opportunity for both income and value-oriented investors at current prices. The convergence of resilient fundamentals, cyclical lows, and imminent sectoral shifts may be setting the stage for Venture Corp to enter a new bullish phase. For those with an eye on quality and a strategy aligned with cash-generative tech exposure, Venture Corp surely deserves a prominent place in any watchlist, if not as a core holding for the coming market cycle.

In the evolving landscape of technology manufacturing, Venture Corp’s compelling fundamentals and timing could position it as one of Singapore’s most promising stories to monitor as 2025 unfolds.

How to buy Venture Corp stock in Singapore?

Buying Venture Corporation Limited (SGX: V03) stock online is simple, accessible, and secure for investors in Singapore—provided you use a regulated brokerage. Today, you can buy Venture Corp shares directly (“spot buying”) for cash and take full ownership, or trade via Contracts for Difference (CFDs) to speculate on price movements with leverage. Both methods are available on leading platforms. Each approach has its own features, costs, and risk levels. Below, we detail both options and encourage you to review a broker comparison further down the page, helping you choose the best platform for your needs.

Spot Buying

Spot (cash) buying means purchasing Venture Corp shares directly through the Singapore Exchange (SGX). You become the legal owner of the shares, benefiting from price appreciation, dividends, and voting rights. Most local brokers in Singapore charge a fixed commission per order—typically ranging from SGD 5 to SGD 25, depending on the platform.

Example

If the Venture Corp share price is SGD 11.07, and you invest SGD 1,000, you can buy around 90 shares (actual: SGD 1,000 minus a brokerage fee of approximately SGD 5, divided by SGD 11.07 per share).

• Gain scenario: If the share price rises by 10%, your 90 shares will be valued at SGD 1,100.
• Result: That’s a +SGD 100 gross gain, or +10% on your original investment (excluding taxes or other minor fees).

Trading via CFD

CFD (Contract for Difference) trading allows you to speculate on Venture Corp’s share price movements—up or down—without owning the actual shares. You can apply leverage (often up to 5x for Singapore stocks), meaning you commit only a fraction of the total trade value up front. CFD trading involves paying the bid-ask spread, and overnight financing fees apply if you hold positions for more than a day.

Example

You open a CFD position on Venture Corp shares with SGD 1,000 capital and 5x leverage.

• Market exposure: SGD 5,000 (SGD 1,000 × 5)
• Gain scenario: If the share price rises by 8%, your exposure increases by 8%, or SGD 400.
• Result: That’s a +40% return (+SGD 400 on your initial SGD 1,000), not accounting for spread and overnight fees.

Final Advice

Before you invest, it is essential to compare brokers’ fees, platform features, trading tools, and customer support—these can significantly impact your returns and experience. The best broker for you depends on your investment objectives: long-term wealth building (usually via spot buying), or more active short-term trading (using CFDs with leverage). Take your time to review the broker comparison tool below to find a platform that matches your goals and budget. Buying Venture Corp shares online is accessible for Singaporeans—and with the right knowledge, you can start your investment journey with confidence.

Our 7 tips for buying Venture Corp stock

The latest news about Venture Corp

Venture Corporation maintains high dividend yield with recent SGD 0.50 per share declaration in May 2025. Despite an 8.20% year-over-year revenue decline and soft market conditions, Venture Corp has reaffirmed its commitment to returning value to shareholders, with an ex-dividend date of May 5, 2025 and the payment scheduled for May 19, 2025. This sustained dividend policy, resulting in a yield of 6.78%, is particularly attractive for Singapore-based income investors given the tax-exempt status of local dividends, and signals management’s confidence in the company’s financial resilience.

The company’s fortress balance sheet supports strategic flexibility and dividend sustainability. Venture Corporation reports a net cash position of SGD 1.32 billion—comprising roughly 35% of its current market capitalisation—and maintains minimal debt, with a debt-to-equity ratio of just 1.04%. This robust liquidity profile underpins its high payout ratio of 88.86% and provides significant buffer to sustain dividends and pursue growth initiatives, even amid revenue softness. Singapore analysts and institutional investors often cite this strong financial base as a key reason for long-term confidence in the counter.

Inclusion in the Straits Times Index reinforces Venture’s relevance in Singapore’s investment landscape. As a component of the STI, Venture Corp benefits from consistent interest from index-tracking funds, enhancing liquidity (average daily volume of 773,130 shares) and ensuring visibility among both local and international investors. The large public float and over one-third institutional ownership reflect ongoing market confidence and offer further depth for both retail and professional market participants.

Recent governance changes mark a new chapter, with Wong Chee Kheong taking the helm as CEO. The appointment of Wong Chee Kheong as CEO from November 1, 2024 is seen as a constructive development, bringing fresh leadership to the group headquartered in Ang Mo Kio, Singapore. Local analysts are watching closely for new strategic directions or operational improvements as the firm navigates evolving market dynamics, especially in high-growth fields such as Life Sciences & MedTech and Next-Gen Communications.

Technical indicators signal weakness, but current price levels offer support for long-term investors. While the stock’s technicals remain subdued—trading below all major moving averages, with an RSI of 42.72 and MACD signaling ‘sell’—the price is hovering near key support levels (SGD 11.04–11.00). Some professional market watchers in Singapore note that despite the lack of short-term bullish momentum, the company’s attractive yield and financial health may prompt value and dividend-focused investors to add positions at these support levels, especially if evidence of a turnaround in topline growth emerges.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.